Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biontech Se ADR (BNTX)

Biontech Se ADR (BNTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,949,832
  • Shares Outstanding, K 226,262
  • Annual Sales, $ 121,620 K
  • Annual Income, $ -200,540 K
  • 60-Month Beta -1.74
  • Price/Sales 144.39
  • Price/Cash Flow N/A
  • Price/Book 22.00
Trade BNTX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.02
  • Number of Estimates 4
  • High Estimate 1.32
  • Low Estimate -1.03
  • Prior Year -0.29
  • Growth Rate Est. (year over year) +93.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.55 +27.21%
on 12/31/20
112.85 -9.20%
on 12/16/20
-8.73 (-7.85%)
since 12/15/20
3-Month
75.35 +36.00%
on 10/28/20
131.00 -21.78%
on 12/11/20
+12.09 (+13.38%)
since 10/15/20
52-Week
28.00 +265.96%
on 03/12/20
131.00 -21.78%
on 12/11/20
+67.92 (+196.58%)
since 01/15/20

Most Recent Stories

More News
Is Vaccine Stock Novavax Still a Buy?

Vaccine specialist Novavax (NVAX) has experienced a steep decline over the past couple of months owing to the delay in its COVID-19 vaccine development. Unfortunately, the delay comes at a time when its...

NVAX : 127.94 (-1.57%)
BNTX : 102.40 (-3.26%)
TECH : 347.57 (+3.08%)
ARWR : 81.84 (-1.23%)
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

PFE : 36.70 (-0.14%)
MRNA : 130.01 (+0.22%)
LLY : 190.84 (+2.22%)
IBB : 162.14 (+0.17%)
CNCR : 34.83 (-0.49%)
XBI : 152.51 (-0.60%)
BBH : 181.23 (+0.68%)
FBT : 176.42 (+0.12%)
SBIO : 56.66 (-0.25%)
PBE : 76.60 (+0.49%)
BTEC : 64.16 (unch)
ARKG : 108.70 (-0.55%)
BNTX : 102.40 (-3.26%)
COVID-19 Vaccine Production to Ramp Up

COVID-19 Vaccine Production to Ramp Up

PFE : 36.70 (-0.14%)
MRNA : 130.01 (+0.22%)
BNTX : 102.40 (-3.26%)
Covid-19 Vaccinations Promise to Ramp Up

Guidance for the end of 2020 was to have 20 million Americans with the first half of the two-injection immunization treatment; as of now, only around 9 million Americans have received the first dose.

PFE : 36.70 (-0.14%)
MRNA : 130.01 (+0.22%)
BNTX : 102.40 (-3.26%)
Moderna (MRNA) Stock Up on Vaccine Pipeline Expansion Plan

Moderna (MRNA) plans to initiate clinical studies on new candidates as potential vaccine for seasonal flu, HIV and the Nipah virus.

JNJ : 160.79 (+0.09%)
AZN : 51.33 (+0.08%)
MRNA : 130.01 (+0.22%)
BNTX : 102.40 (-3.26%)
Health Officials Warn Of COVID-19 Vaccine Shortages Across Canada

Health authorities across Canada are warning that they’re running low on COVID-19 vaccines. The ...

PFE : 36.70 (-0.14%)
BNTX : 102.40 (-3.26%)
MRNA : 130.01 (+0.22%)
GSK : 38.46 (+0.79%)
CureVac (CVAC) Up on Deal With Bayer for COVID-19 Vaccine

CureVac (CVAC) gains on a collaboration agreement with Bayer (BAYRY) for further development and supply of its COVID-19 vaccine candidate, CVnCoV.

PFE : 36.70 (-0.14%)
BAYRY : 15.8150 (-1.40%)
BNTX : 102.40 (-3.26%)
CVAC : 100.40 (-0.19%)
Thinking about trading options or stock in Nio, Plug Power, Pfizer, Sorrento Therapeutics, or BioNTech?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIO, PLUG, PFE, SRNE, and BNTX.

BNTX : 102.40 (-3.26%)
PLUG : 61.91 (-6.96%)
SRNE : 9.46 (+18.40%)
NIO : 56.37 (-7.39%)
PFE : 36.70 (-0.14%)
Pfizer-BioNTech COVID-19-Impfstoff lost in vitro neutralisierende Antikorperantwort gegen SARS-CoV-2 mit einer Mutation aus, die mit einer schnellen Ubertragung assoziiert wird

New York und Mainz, Deutschland 08. Januar 2021 -- Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX) gaben heute Ergebnisse einer in vitro-Studie bekannt, die zeigen, dass Personen, die den Pfizer-BioNTech-COVID-19-Impfstoff...

PFE : 36.70 (-0.14%)
BNTX : 102.40 (-3.26%)
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission

New York and Mainz, Germany, January 8, 2021 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and the University of Texas Medical...

PFE : 36.70 (-0.14%)
BNTX : 102.40 (-3.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

See More

Key Turning Points

3rd Resistance Point 111.72
2nd Resistance Point 109.11
1st Resistance Point 107.48
Last Price 102.40
1st Support Level 103.24
2nd Support Level 100.63
3rd Support Level 99.00

See More

52-Week High 131.00
Last Price 102.40
Fibonacci 61.8% 91.65
Fibonacci 50% 79.50
Fibonacci 38.2% 67.35
52-Week Low 28.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar